Are you comfortable discussing the benefits and risks of screening?
Prostate cancer is the most commonly diagnosed cancer in Nevada (excluding non-melanoma skin cancers), and is the #2 cancer killer among men.
Despite the prevalence of this cancer, research has not yet proven if the potential benefits of prostate cancer screening outweigh the limitations of the testing and treatment. Most major health organiztions recommend health care providers discuss screening with their patients to help them make an informed decision about whether to be tested for prostate cancer.
The US Preventive Services Task Force recommends: "For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)–based screening for prostate cancer should be an individual one. Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision...The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years and older." Review the full recommendation here.
Materials and Resources
|"Is Prostate Cancer Screening Right for You" Decision Aid for Patients, USPSTF May 2018||Download PDF|
|Prostate Cancer Awareness Month Social Media Toolkit||Download PDF|
|Prostate Cancer in Nevada Infographic - 2018||Download PDF|